Neuroscience News at Yale

A Yale School of Medicine-built platform uncovers genes associated with dysfunctional molecular clusters in cells—and drug candidates to prevent them.

Michelle Monje, MD, PhD, will give the 2026 Kavli Distinguished Lecture on Tuesday, Sept. 22, titled "Neuron-Glial Interactions in Health and Disease: from Cognition to Cancer."

In a new study, Yale researchers identified an unexpected mechanism that challenges a long-held assumption about the brain’s hunger circuitry.

The Center for the Translational Neuroscience of Alcohol (CTNA) at Yale School of Medicine has been awarded a grant by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to continue its research for five more years.

The 2026 SYNAPSES (Symposia at Yale Neuroscience: Advanced PoStdoc Extramural Series) Symposium will be held on October 22, 2026. SYNAPSES brings postdocs from around the world to Yale to share their latest work.

The Center for Neuroethology and Physiological Plasticity will coordinate research on how behaviors and senses arise and differ across species.

Yale School of Medicine (YSM) researchers have identified for the first time the brain signals responsible for unconscious action – actions taken by the body that we aren’t consciously aware of until after they’re complete.

Mutations in VPS13 proteins are associated with neurodegenerative conditions like Parkinson’s disease. New findings could point to therapeutic avenues.

A new study uncovers the structure of a toxic form of amyloid beta driving brain damage associated with Alzheimer’s disease.